B-Cell Malignant Neoplasm — Trials

B-Cell Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,464 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,083
Recruiting: 1,078
Ph III recruiting: 121
Growth YoY: +5.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,165)

clinicaltrialsPublishedShowing 101–150 of 7,464 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06910670	Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid	active not recruiting	N/A	197	Washington University School of MedicineOTHER	1	Sep 25, 2026	clinicaltrials
NCT06929624	A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma	active not recruiting	Phase 3	282	Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY	1	Sep 25, 2026